FDA Fast Track Development Program

Results: 173



#Item
61Biosimilar / Hospira / Food and Drug Administration / Biologic / Clinical pharmacy / Pharming / Pharmaceutical industry / FDA Fast Track Development Program / Clinical trial / Pharmacology / Pharmaceutical sciences / Clinical research

Volume 11, Number 8 August 2014 News and Strategies for Managing High-Cost Specialty Products

Add to Reading List

Source URL: aishealth.com

Language: English - Date: 2014-08-15 14:40:44
62Health / Clinical research / Pharmaceuticals policy / Pharmaceutical industry / Prescription Drug User Fee Act / European Medicines Agency / FDA Fast Track Development Program / Biologic / Clinical trial / Food and Drug Administration / Pharmaceutical sciences / Pharmacology

Report: Complex Issues in Developing Drugs and Biological Products for Rare Diseases and Accelerating the Development of Therapies for Pediatric Rare Diseases

Add to Reading List

Source URL: www.fda.gov.

Language: English
63Food and Drug Administration / Pharmaceutical industry / Clinical pharmacology / Pharmaceuticals policy / FDA Fast Track Development Program / Center for Drug Evaluation and Research / Drug development / Medical device / Generic drug / Pharmaceutical sciences / Medicine / Pharmacology

Breakthrough Therapies: Leveraging Best Practices from Expedited Reviews AAPS Annual Meeting San Antonio, Texas November 11, 2013

Add to Reading List

Source URL: www.fda.gov

Language: English
64Prostate cancer / Breast cancer / Radiation therapy / Oncology / FDA Fast Track Development Program / Food and Drug Administration / Oxaliplatin / Metastatic breast cancer / Glioblastoma multiforme / Medicine / Ribbon symbolism / Radiation oncology

End Points and United States Food and Drug Administration Approval of Oncology Drugs By John R. Johnson, Grant Williams, and Richard Pazdur Purpose: To summarize the end points used by the United States Food and Drug Adm

Add to Reading List

Source URL: www.fda.gov

Language: English
65Research / Clinical trials / Medical statistics / Medical research / Medical terms / FDA Fast Track Development Program / Surrogate endpoint / Randomized controlled trial / Food and Drug Administration / Medicine / Health / Epidemiology

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
66Health / Food and Drug Administration / Drug discovery / Pharmaceutical industry / Pharmaceuticals policy / Pharmacovigilance / FDA Fast Track Development Program / Clinical trial / Prescription Drug User Fee Act / Pharmaceutical sciences / Pharmacology / Medicine

Project FDA Report No. 6 May 2013 The Digital Future of Molecular Medicine: Rethinking FDA Regulation

Add to Reading List

Source URL: www.manhattan-institute.org

Language: English - Date: 2013-05-14 16:39:39
67Clinical trials / Epidemiology / Medical research / Medical terms / Medical statistics / Surrogate endpoint / FDA Fast Track Development Program / Clinical endpoint / Food and Drug Administration / Medicine / Health / Research

Regulatory Background: Ovarian Cancer Clinical Endpoints

Add to Reading List

Source URL: www.fda.gov

Language: English
68Clinical trials / Food and Drug Administration / Medical terms / Medical statistics / Medical research / FDA Fast Track Development Program / Surrogate endpoint / End point of clinical trials / Progression-free survival / Medicine / Health / Clinical research

FDA Approvals in Multiple Myelomar

Add to Reading List

Source URL: www.fda.gov

Language: English
69Cancer / FDA Fast Track Development Program / Medicine / Adjuvant therapy / Colorectal cancer

1st draft of Colon Cancer Workshop Agenda (to begin the discussion)

Add to Reading List

Source URL: www.fda.gov

Language: English
70Food and Drug Administration / Clinical research / Viral load / Virology / HIV / FDA Fast Track Development Program / Surrogate endpoint / HIV test / Index of AIDS-related articles / HIV/AIDS / Medicine / Health

Clinical Benefit for New Drug Approvals Albert Deisseroth, M.D., Ph.D. Division of Hematology Products (DHP) Office of Hematology and Oncology Products (OHOP) Office of New Drugs (OND), CDER, FDA

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE